We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$16.8B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
-0.36%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$50.5B
AUM Growth
-$441M
(-0.86%)
Cap. Flow
-$99.6M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
12.69%
Holding
1,684
New
109
Increased
555
Reduced
507
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$562M |
| 2 |
Xerox
XRX
|
+$122M |
| 3 |
Edison International
EIX
|
+$103M |
| 4 |
Biogen
BIIB
|
+$97.3M |
| 5 |
Waste Management
WM
|
+$91.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$650M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$162M |
| 3 |
Booking.com
BKNG
|
+$154M |
| 4 |
Perrigo
PRGO
|
+$147M |
| 5 |
Qorvo
QRVO
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.16% |
| 2 | Financials | 12.55% |
| 3 | Technology | 10.88% |
| 4 | Industrials | 10.41% |
| 5 | Energy | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
BioCryst Pharmaceuticals
BCRX
$2.37B
| $1.7M | ﹤0.01% |
113,635
+3,243
| +3% | +$36.9K |
|
1052
The GEO Group
GEO
$4.13B
| $1.7M | ﹤0.01% |
+74,448
| New | +$1.92M |
|
|
STKL
1053
DELISTED
SunOpta
STKL
| $1.7M | ﹤0.01% |
157,990
+15,430
| +11% | +$163K |
|
1054
Darling Ingredients
DAR
$9.93B
| $1.69M | ﹤0.01% |
115,100
| – | – |
|
|
TARO
1055
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.68M | ﹤0.01% |
11,693
+5,131
| +78% | +$732K |
|
1056
Winnebago Industries
WGO
$870M
| $1.68M | ﹤0.01% |
71,143
| – | – |
|
|
EVER
1057
DELISTED
Everbank Financial Corp
EVER
| $1.66M | ﹤0.01% |
+84,700
| New | +$1.58M |
|
|
NMBL
1058
DELISTED
Nimble Storage, Inc.
NMBL
| $1.66M | ﹤0.01% |
59,264
+10,676
| +22% | +$279K |
|
|
VER
1059
DELISTED
VEREIT, Inc.
VER
| $1.66M | ﹤0.01% |
40,831
-60,805
| -60% | -$2.74M |
|
|
PN
1060
DELISTED
Patriot National, Inc.
PN
| $1.66M | ﹤0.01% |
103,549
+1,785
| +2% | +$27.2K |
|
1061
Rogers Corp
ROG
$2.33B
| $1.65M | ﹤0.01% |
25,000
| – | – |
|
1062
Cabot Corp
CBT
$4.65B
| $1.64M | ﹤0.01% |
44,000
| – | – |
|
|
RKT
1063
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $1.64M | ﹤0.01% |
27,200
-3,800
| -12% | -$240K |
|
1064
Kohl's
KSS
$2.03B
| $1.61M | ﹤0.01% |
25,702
-5,997
| -19% | -$416K |
|
1065
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $1.59M | ﹤0.01% |
+79,445
| New | +$1.55M |
|
1066
VanEck High Yield Muni ETF
HYD
$4.44B
| $1.58M | ﹤0.01% |
26,400
-13,500
| -34% | -$833K |
|
|
XOMA
1067
DELISTED
Xoma
XOMA
| $1.57M | ﹤0.01% |
+20,210
| New | +$1.46M |
|
|
WR
1068
DELISTED
Westar Energy Inc
WR
| $1.56M | ﹤0.01% |
45,500
+7,000
| +18% | +$256K |
|
|
MKTO
1069
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $1.55M | ﹤0.01% |
55,400
-26,897
| -33% | -$772K |
|
|
POZN
1070
DELISTED
POZEN INC
POZN
| $1.55M | ﹤0.01% |
150,000
+62,500
| +71% | +$515K |
|
|
GHDX
1071
DELISTED
Genomic Health, Inc.
GHDX
| $1.53M | ﹤0.01% |
55,000
+17,420
| +46% | +$491K |
|
|
RCPT
1072
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.52M | ﹤0.01% |
+8,000
| New | +$1.32M |
|
1073
Atmos Energy
ATO
$29.9B
| $1.51M | ﹤0.01% |
29,500
| – | – |
|
|
ADPT
1074
DELISTED
Adeptus Health Inc
ADPT
| $1.51M | ﹤0.01% |
+15,927
| New | +$1.1M |
|
1075
China Automotive Systems
CAAS
$131M
| $1.51M | ﹤0.01% |
179,438
+131,160
| +272% | +$1.02M |
|
Similar funds
AIMCA
CI
BCIM
VMPIC
EIP
PP
ASRS
CM
Macquarie Group's Q2 2015 Portfolio in Review
As of Q2 2015, Macquarie Group held 1,684 positions worth $50.5B, down 0.86% from $51B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Macquarie Group's Q2 2015 filing shows 109 new, 555 increased, 507 reduced and 75 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 928,884 shares worth $36.8M. The largest sale was BROADCOM CORP CL-A, an estimated $650M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- Macquarie Group's largest Q2 2015 buy was iShares MSCI Emerging Markets ETF: 928,884 shares worth $36.8M.
- Macquarie Group added most to Express Scripts Holding Company in Q2 2015, an estimated $562M increase.
- Macquarie Group's biggest Q2 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $650M.
- Macquarie Group fully exited Cooper Companies in Q2 2015, selling an estimated $55.8M.
- Macquarie Group's ten largest holdings make up 13% of its $50.5B portfolio in Q2 2015.
- Macquarie Group opened 109 new positions and closed 75 in Q2 2015.
- Macquarie Group's portfolio value fell 0.86% quarter-over-quarter to $50.5B.
Based on Macquarie Group's 13F filing for Q2 2015, filed 14 Aug 2015.